M&A Deal Summary |
|
|---|---|
| Date | 2021-12-02 |
| Target | SwiftScale Biologics |
| Sector | Life Science |
| Buyer(s) | Resilience |
| Deal Type | Add-on Acquisition |
SEARCH BY
Resilience is a manufacture and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption. The company is building a sustainable network of high-tech, end-to-end manufacturing solutions to ensure the medicines of today and tomorrow can be made quickly, safely, and at scale. Resilience was founded in 2020 and is based in San Diego, California.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2021 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-04-12 |
Ology Bioservices
Alachua, Florida, United States Ology Bioservices integrated biopharmaceutical company with a focus on development and manufacturing as well as having expertise in preclinical and clinical development, formulation optimization, and CGMP manufacturing of biopharmaceutical products and medical devices. Ology Bioservices was formed in 1999 and is based in Alachua, Florida. |
Buy | - |
